139 related articles for article (PubMed ID: 31154837)
1. A clinical comparison between dedifferentiated low-grade osteosarcoma and conventional osteosarcoma.
Toki S; Kobayashi E; Yoshida A; Ogura K; Wakai S; Yoshimoto S; Yonemori K; Kawai A
Bone Joint J; 2019 Jun; 101-B(6):745-752. PubMed ID: 31154837
[TBL] [Abstract][Full Text] [Related]
2. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
5. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
6. Primary extraskeletal osteosarcoma: a clinicopathological study of 18 cases focusing on MDM2 amplification status.
Yamashita K; Kohashi K; Yamada Y; Nishida Y; Urakawa H; Oda Y; Toyokuni S
Hum Pathol; 2017 May; 63():63-69. PubMed ID: 28235629
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study.
Hirai T; Kobayashi H; Kobayashi E; Saito M; Akiyama T; Kikuta K; Nakai T; Endo M; Tsukamoto S; Hakozaki M; Takenaka S; Nishimura S; Kawashima H; Tanzawa Y; Kawano H; Tanaka S
Int J Clin Oncol; 2022 Nov; 27(11):1758-1766. PubMed ID: 35932377
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated low-grade central osteosarcoma with extensive cystic change initially treated as a simple bone cyst.
Toya M; Yamada Y; Yokoyama R; Taguchi K; Nabeshima K; Isayama T; Oda Y
Pathol Res Pract; 2020 Apr; 216(4):152832. PubMed ID: 32057514
[TBL] [Abstract][Full Text] [Related]
9. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome.
Sheth DS; Yasko AW; Raymond AK; Ayala AG; Carrasco CH; Benjamin RS; Jaffe N; Murray JA
Cancer; 1996 Nov; 78(10):2136-45. PubMed ID: 8918422
[TBL] [Abstract][Full Text] [Related]
10. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
[TBL] [Abstract][Full Text] [Related]
12. Can imaging distinguish between low-grade and dedifferentiated parosteal osteosarcoma?
Lin HY; Hondar Wu HT; Wu PK; Wu CL; Chih-Hsueh Chen P; Chen WM; Guo WY
J Chin Med Assoc; 2018 Oct; 81(10):912-919. PubMed ID: 30190236
[TBL] [Abstract][Full Text] [Related]
13. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
[TBL] [Abstract][Full Text] [Related]
14. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
15. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma.
Laitinen M; Parry M; Albergo JI; Jeys L; Abudu A; Carter S; Sumathi V; Grimer R
Bone Joint J; 2015 Dec; 97-B(12):1698-703. PubMed ID: 26637687
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated parosteal osteosarcoma of the maxilla: a case report and review of the literature.
Miyashita H; Yoshida K; Soma T; Kameyama K; Sasaki A; Hisaoka M; Yazawa M; Morioka H; Takahashi M; Nakagawa T; Kawana H
J Med Case Rep; 2018 Aug; 12(1):235. PubMed ID: 30115116
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and comprehensive treatment of skull base osteosarcoma].
Hu K; Wan J; Ni S; Li X; Liu S; Meng X; Qian H
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):383-6. PubMed ID: 26463032
[TBL] [Abstract][Full Text] [Related]
19. Gene amplification and tumor grading in parosteal osteosarcoma.
Chen PC; Yen CC; Hung GY; Pan CC; Chen WM
J Chin Med Assoc; 2019 Dec; 82(12):889-894. PubMed ID: 31634336
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.
Ozaki T; Flege S; Kevric M; Lindner N; Maas R; Delling G; Schwarz R; von Hochstetter AR; Salzer-Kuntschik M; Berdel WE; Jürgens H; Exner GU; Reichardt P; Mayer-Steinacker R; Ewerbeck V; Kotz R; Winkelmann W; Bielack SS
J Clin Oncol; 2003 Jan; 21(2):334-41. PubMed ID: 12525527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
